Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo, Japan.
Department of Nephrology, International University of Health and Welfare Narita Hospital, Chiba, Japan.
Hypertens Res. 2023 Sep;46(9):2192-2202. doi: 10.1038/s41440-023-01364-1. Epub 2023 Jul 7.
Predialysis systolic blood pressure (SBP) in patients on hemodialysis (HD) consistently followed a seasonal pattern, reaching a peak in winter and nadir in summer, similar to blood pressure in the general population. However, the relationship between seasonal variations in predialysis SBP and clinical outcomes is still under-investigated in Japanese patients on HD. This retrospective cohort study included 307 Japanese patients undergoing HD for >1 year in three dialysis clinics and evaluated the association between the standard deviation (SD) of predialysis SBP and clinical outcomes, including major adverse cardiovascular events (MACEs; cardiovascular death, nonfatal myocardial infarction or unstable angina, stroke, heart failure, and other severe cardiovascular events requiring hospitalization) with 2.5 years follow-up. The SD of predialysis SBP was 8.2 (6.4-10.9) mmHg. In the model fully adjusted for the SD of predialysis SBP, predialysis SBP, age, sex, HD vintage, Charlson comorbidity index, ultrafiltration rate, renin-angiotensin system inhibitors, corrected calcium, phosphorus, human atrial natriuretic peptide, C-reactive protein, albumin, hemoglobin, body mass index, normalized protein catabolism rate, and intradialytic SBP decline, Cox regression analyses showed that a higher SD of predialysis SBP (per 10 mmHg) was significantly associated with increased MACE risk (hazard ratio [HR], 1.89; 95% confidence interval [95% CI], 1.07-3.36) and all-cause hospitalization (HR, 1.57; 95% CI, 1.07-2.30). Therefore, greater seasonal variations in predialysis SBP were associated with worse clinical outcomes, including MACEs and all-cause hospitalization. Whether interventions to reduce seasonal variations in predialysis SBP will improve the prognosis of Japanese patients on HD must be investigated further.
血液透析患者的透析前收缩压(SBP)始终呈现季节性变化模式,冬季达到峰值,夏季达到谷值,与普通人群的血压变化相似。然而,在日本血液透析患者中,透析前 SBP 季节性变化与临床结局之间的关系仍研究不足。这项回顾性队列研究纳入了在三个透析中心接受血液透析治疗>1 年的 307 名日本患者,并评估了透析前 SBP 标准差(SD)与临床结局(包括主要不良心血管事件[MACE];心血管死亡、非致死性心肌梗死或不稳定型心绞痛、卒中和心力衰竭以及其他需要住院治疗的严重心血管事件)之间的相关性,随访时间为 2.5 年。透析前 SBP 的 SD 为 8.2(6.4-10.9)mmHg。在充分调整了透析前 SBP 的 SD 后, Cox 回归分析显示,较高的透析前 SBP SD(每 10mmHg)与更高的 MACE 风险(风险比[HR],1.89;95%置信区间[95%CI],1.07-3.36)和全因住院(HR,1.57;95%CI,1.07-2.30)显著相关。因此,透析前 SBP 更大的季节性变化与更差的临床结局相关,包括 MACE 和全因住院。是否干预以降低透析前 SBP 的季节性变化将改善日本血液透析患者的预后,这需要进一步研究。